When was Avid Bioservices founded?

Avid Bioservices was founded in 2002 and raised its 1st funding round 7 years after it was founded.

Where is Avid Bioservices located?

Avid Bioservices is headquartered in Orange, United States.

How many employees does Avid Bioservices have?

As of Jul 31, 2026, the latest employee count at Avid Bioservices is 401.

Is Avid Bioservices a funded company?

Avid Bioservices is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 29, 2009.

When was the latest funding round of Avid Bioservices?

Avid Bioservices' latest funding was a $***** Grant (prize money) round on Sep 11, 2009, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $646M in funding in 2026 to date.

What is the annual revenue of Avid Bioservices?

Annual revenue of Avid Bioservices is between $100M and $500M as on Apr 30, 2024

Where does Avid Bioservices rank among its competitors?

Avid Bioservices ranks 3rd amongst 44 active competitors, of which 4 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Kashiv BioSciences, which secured $72.3M in Dec, 2025.

Who are the top competitors of Avid Bioservices?

Avid Bioservices' top competitors include Bionova Scientific, Just Biotherapeutics and JHL Biotech. Among them, Kashiv BioSciences secured the most recent funding round in December, 2025.

Avid Bioservices - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

CDMO focused on drug substance development, analytical, and quality & regulatory compliance services. Their portfolio which provides CGMP manufacturing, stability testing, process validation support, and inspection services.

Website: avidbio.com
Social
Part Of

Key Metrics

Founded Year

2002

Location

Orange, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Sep 11, 2009, $*****

Investors

Ranger Investments & 4 more

Ranked

3^rd among 44 active competitors

Annual Revenue

$100M - $500M as on Apr 30, 2024

Employee Count

401 as on Jul 31, 2026

Similar Companies

Bionova Scientific & 51 more

Exit Details

Acquired by GHO Capital Partners (Nov 07, 2024)

View Avid Bioservices' full profile

Avid Bioservices is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Peregrine Pharmaceuticals, Inc. CIN: 953698422 , United States, Active	Dec 31, 1999	-	375 (As on Dec 31, 2024)	-
AVID BIOSERVICES, INC. CIN: 704562 , United States, Active	Sep 24, 1996	$100M - $500M (As on Apr 30, 2024)	-	-

Avid Bioservices got acquired by GHO Capital Partners and Ampersand Capital on Nov 07, 2024.

Click here to take a look at Avid Bioservices's acquisition in detail

Avid Bioservices has raised funding over 2 rounds. Its first funding round was on Jul 29, 2009. Its latest funding round was a Grant (prize money) round on Sep 11, 2009 for $*****. 1 investor participated in its latest round. Avid Bioservices has 5 institutional investors.

Here is the list of recent funding rounds of Avid Bioservices:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 11, 2009	6359683	Grant (prize money)	2736626	3265151	9924079	9775851
Jul 29, 2009	6614278	Grant (prize money)	2963828	5241657	8443728	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Avid Bioservices's funding rounds and investors

The founders of Avid Bioservices is Edward Legere. Nicholas Green is the CEO of Avid Bioservices.

Here are the details of Avid Bioservices' key team members:

Edward Legere: Founder of Avid Bioservices and founder of 1 other company.

View details of Avid Bioservices's Founder profiles and Board Members

Avid Bioservices' employee count trend

Avid Bioservices has 401 employees as of Jul 26. Here is Avid Bioservices's employee count trend over the years:

Employee count trend for Avid Bioservices

Uncover Avid Bioservices' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Avid Bioservices include Bionova Scientific, Just Biotherapeutics and JHL Biotech. Here is the list of Top 10 competitors of Avid Bioservices, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bionova Scientific 2013, Fremont (United States), Acquired	Contract Research and Development company developing mammalian cell culture biologics	$22M	CRG, Great Point Partners	54/100
2nd	Just Biotherapeutics 2014, Seattle (United States), Acquired	Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs	$124M	Lilly Asia Ventures, Temasek & 10 others	53/100
3rd	Avid Bioservices 2002, Orange (United States), Acquired	CDMO focused on drug substance development, analytical, and quality & regulatory compliance services	-	Ranger Investments, Ampersand Capital & 3 others	51/100
4th	JHL Biotech 2012, Hsinchu (Taiwan), Series D	CDMO solutions to companies developing and commercializing affordable biologics	$187M	Sequoia Capital, Sanofi & 11 others	51/100
5th	Rentschler Biopharma 1927, Laupheim (Germany), Funding Raised	Full-service CDMO for biopharmaceuticals	-	-	50/100
6th	64x Bio 2017, San Francisco (United States), Series A	Developer of cell lines and production technologies for advanced therapies	$59.6M	First Round Capital, Fifty Years & 13 others	48/100
7th	Excellgene 2001, Monthey (Switzerland), Acquired	Provider of service covering value chain from DNA vector to purified protein	-	Kulczyk Investments, BioArk	48/100
8th	Kashiv BioSciences 2010, Piscataway (United States), Acquired	Developer of biosimilar medicines	-	GoldenTree	48/100
9th	ProBioGen AG 1994, Berlin (Germany), Acquired	Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars	-	SudBG, SHS & 2 others	45/100
10th	AGC Biologics 2018, Bothell (United States), Unfunded	CDMO focused on development of mammalian and microbial-based therapeutic proteins	-	European Equity Partners	43/100